Free Trial

Exozymes (NASDAQ:EXOZ) Shares Up 3.9% - Still a Buy?

Exozymes logo with Medical background

Exozymes Inc. (NASDAQ:EXOZ - Get Free Report) was up 3.9% on Tuesday . The stock traded as high as $13.99 and last traded at $13.96. Approximately 1,355 shares traded hands during mid-day trading, a decline of 92% from the average daily volume of 17,489 shares. The stock had previously closed at $13.44.

Exozymes Price Performance

The firm's 50 day moving average price is $12.63.

Exozymes (NASDAQ:EXOZ - Get Free Report) last released its quarterly earnings data on Monday, May 12th. The company reported ($0.22) earnings per share for the quarter.

About Exozymes

(Get Free Report)

eXoZymes, Inc is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.

Further Reading

Should You Invest $1,000 in Exozymes Right Now?

Before you consider Exozymes, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exozymes wasn't on the list.

While Exozymes currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines